Key points are not available for this paper at this time.
BEZ235 twice daily resulted in significant toxicity without objective responses; further development of this compound will not be pursued in this disease.
Carlo et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: